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Abstract
Background: Nasopharyngeal carcinoma (NPC) and other head and neck cancer (HNCA) types
show a great epidemiological variation in different regions of the world. NPC has multifactorial
etiology and many interacting risk factors are involved in NPC development mainly Epstein Barr
virus (EBV). There is a need to scrutinize the complicated network of risk factors affecting NPC
and how far they are different from that of other HNCA types.
Methods: 122 HNCA patients and 100 control subjects were studied in the region of the Middle
East. Three types of HNCA were involved in our study, NPC, carcinoma of larynx (CL), and
hypopharyngeal carcinoma (HPC). The risk factors studied were the level of EBV serum IgG and
IgA antibodies measured by ELISA, age, sex, smoking, alcohol intake, histology, and family history
of the disease.
Results: EBV serum level of IgG and IgA antibodies was higher in NPC than CL, HPC, and control
groups (p < 0.01). NPC was associated with lymphoepithelioma (LE) tumors, males, regular alcohol
intake, and regular smoking while CL and HPC were not (p < 0.05). CL and HPC were associated
with SCC tumors (p < 0.05). Furthermore, NPC, unlike CL and HPC groups, was not affected by
the positive family history of HNCA (p > 0.05). The serum levels of EBV IgG and IgA antibodies
were higher in LE tumors, regular smokers, younger patients, and negative family history groups of
NPC patients than SCC tumors, non-regular smokers, older patients and positive family history
groups respectively (p < 0.05) while this was not found in the regular alcoholics (p > 0.05).
Conclusion: It was concluded that risk factors of NPC deviate much from that of other HNCA.
EBV, smoking, alcohol intake, LE tumors, male patient, and age > 54 years were hot risk factors of
NPC while SCC and positive family history of the disease were not. Earlier incidence, smoking, LE
tumors, and negative family history of the disease in NPC patients were associated much clearly
with EBV. It is proposed that determining the correct risk factors of NPC is vital in assigning the
correct risk groups of NPC which helps the early detection and screening of NPC.
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Background
Nasopharyngeal carcinoma (NPC) was shown to be dis-
tinct from other head and neck cancer (HNCA) types in
terms of histopathological spectrum, and geographical
distribution [1]. In the Western world, NPC is an uncom-
mon type of tumor. In the USA, NPC represents less than
1% of all cancers. The annual incidence in the USA and
Europe varies between 0.22 and 0.5 per 100 000 popula-
tion [2,3]. In contrast, NPC is widely prevalent in South
East Asia, the Middle East, and North Africa where higher
incidence of NPC has been reported than other parts of
the world [4,5]. However, China and Southeast Asian
countries have been considered as the highest incidence
regions for NPC in the world where incidence could reach
20 to 50 per 100 000 individuals [4-8]. Nevertheless, high
NPC incidence rate, 92/100,000 was found in some parts
of the Middle East in 2002–2003 [9]. These figures are sur-
prisingly higher than that in China and South East Asia
making the Middle East region as one of the highly
endemic regions for NPC. Unfortunately, the high inci-
dence of NPC in this region has long been underesti-
mated. Moreover, the risk factors of NPC development
have not been studied thoroughly in this region of the
world.
NPC is highly metastatic and invasive malignant tumor.
Approximately 90% of NPC patients show malignant cer-
vical lymph nodes [10]. Epstein-Barr virus (EBV) is con-
sidered as one of the main etiological factors of NPC,
which is an oncogenic herpesvirus associated with a vari-
ety of malignancies in T cells, B cells, and epithelial cells
[11]. EBV establishes a life-long persistent infection in
over 90% of the human adult population worldwide [12].
EBV has been linked to the development of a variety of
human malignancies of lymphoid and epithelial origin,
including Burkitts lymphoma, Hodgkin's lymphoma, and
NPC [13].
In this study, NPC patients were the core group for the
comparison with other HNCA patients in terms of the
studied risk factors namely, age, sex, staging of the disease,
histology of the tumors, smoking, alcohol intake, family
history of the disease, and EBV serology. The aim of this
study was to evaluate precisely the essential risk factors
and assign correctly the high risk groups of NPC and other
HNCA types in the population of the Middle East where a
remarkable shortage of research has been present.
Methods
The population of the study
One hundred twenty two HNCA patients were selected
without any bias to any type during the period between
January 2006 to January 2008 in the University hospital of
the Medical College of Alnahrain University and Radio-
therapy Reference Center in Baghdad, Iraq, and from
Alhussein Hospital in Amman, Jordan. The samples were
processed and the study was totally conducted in Univer-
sity Putra Malaysia (UPM). HNCA patients were involved
after the diagnosis was established. Primary HNCA cases
were selected rather than secondary or recurrent cases.
HNCA patients were 42 NPC patients, 66 carcinoma of
larynx (CL), and 14 hypopharyngeal carcinoma (HPC)
patients. HNCA patients and control subjects in Iraq and
Jordan were native Middle Eastern people of Arabic eth-
nicity. Twenty patients of other HNCA types that were of
small sample size, less than 6 patients, were neglected for
statistical purposes such as tongue, retromalar, tonsillar,
epiglottic and post-pharyngeal carcinomas. The age of
HNCA patients ranged between 16 to 74 years old,
median, 53 years and mean 51.8 years. The median age of
NPC patients was 54.4 years and the mean age was 54
years. For HPC patients, the median age was 62.5 years
and the mean age was 62.16 years. For CL patients, the
median age was 50.5 years and the mean age was 50.81
years. HNCA patients were 89 (72.9%) males and 33
(27%) females at male:female ratio, 2.6:1. NPC patients
were 9 (21.4%) females and 33 (78.5%) males revealing
male predominance at sex ratio, 3.6:1. HPC patients were
12 (85.7%) females and 2 (14.3%) males with females
predominance at sex ratio 1:6. CL patients were 6 (9%)
females and 60 (91%) males with clear male predomi-
nance at sex ratio 10:1. HNCA staging was based on TNM
system by which HNCA patients were classified into 4
stages, depending on T (the extent of primary tumor), N
(regional LN spread) and M (distant metastasis) [14].
Accordingly, the studied HNCA patients were diagnosed
at different stages of the disease, 68% at stage IV, 21% at
stage III, 7% at stage II, and 4% at stage I.
One hundred age- and sex- matched control subjects were
selected. Control subjects were those who attended hospi-
tals for minor traumatic therapy. They showed normal
blood and biochemical laboratory tests, namely differen-
tial blood count, hemoglobin level, total serum proteins,
liver function tests, erythrocytes sedimentation rate, kid-
ney function tests, and C-reactive proteins as well as were
medically tested by a specialist and found free of HNCA or
any other medical illness.
The survey data and sampling
Direct interview was done with HNCA patients. The data
sheet for survey encompassed name, age, sex, smoking,
the number of smoked cigarettes per day, how many years
the smoking habit has been, alcohol consumption, level
and duration of alcohol consumption, the type of alcohol
drink, the family history of HNCA (parents, brothers/sis-
ters, cousins and children). Moreover, the past and recent
medical records and the reports of histopathology of the
involved patients were reviewed. The cutoff line of regular
smoking (smoking > 10 cigarettes per day more than 10BMC Public Health 2008, 8:400 http://www.biomedcentral.com/1471-2458/8/400
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years) was used in this study. In terms of Brinkman index,
number of cigarettes smoked per day multiplied by
number of years of smoking, this cutoff line is equal to
100. The cutoff line for regular alcohol consumption is
equal to or more than 2 glasses per day (about 400–500
mL/day) of drinks with alcohol concentration more than
12% for 10 years and more. This is equal to ethanol con-
sumption > 210 g/week for more than 10 years. Above
this cutoff value, individuals were considered regular alco-
holics [15].
Sera were sampled from HNCA patients before the begin-
ning of chemotherapy or surgery and from control sub-
jects after excluding any HNCA and other medical illness.
Sera were used to estimate the serum level of EBV IgG and
IgA antibodies via ELISA. After surgery, paraffin embed-
ded sections were retrieved from the excisional biopsies of
HNCA primary tumors. The histopathological examina-
tion and classification was carried out by a histologist. The
histopathology of HNCA tumor sections was assessed and
classified for purposes of comparison into two main
groups; well-differentiated squamous cell carcinoma
(SCC) and undifferentiated lymphoepithelioma (LE).
Written consents were granted by HNCA patients and
control subjects. The procedures of specimens sampling
and patient interviewing were done according to the
guidelines of Helsinki declaration for the ethics of the bio-
medical research. Official permission was granted by the
regional Ethics committee of medical research in Baghdad
and Amman clinical institutes.
ELISA for Epstein Barr virus serum antigens
EBV viral capsid antigen (VCA) (Wellcome) was used for
coating the solid phase of 96 wells microtiter plates. The
antigen was diluted 1:10 in carbonate-bicarbonate coat-
ing buffer (1.59 g/L carbonate & 2.93 g/L bicarbonate)
(Sigma). After a series of standardization steps, 50 μl/well
of the EBV antigen in coating buffer were added for over-
night at 4°C. Next day, the remaining fluid was aspirated
and wells were washed twice with washing buffer (PBS
from Sigma, 1% BSA w/v from Merck, 0.05% v/v Tween
20 from Merck). Blocking buffer (PBS, 1% BSA w/v) was
then added for 1 hour. After washing step, 50 ul/well of
non-diluted serum of HNCA patients and control subjects
were added in duplicates. The ELISA plate was incubated
for 2 hours at 37°C. Two sets of ELISA were pursued, the
first for detecting EBV serum IgG antibodies and the sec-
ond for detecting EBV serum IgA antibodies. After wash-
ing step, 50 ul/well of horseradish peroxidase-labeled
rabbit anti-human IgG and IgA antibodies were added at
1:40 and 1:100 dilution respectively of original concentra-
tion 2 mg/mL for anti-human IgG and 3 mg/mL for anti-
human IgA (ICN immunologicals). After washing step, 50
ul of the chromogen-substrate, OPD-H2O2, (Sanofi diag-
nostics) were added and incubated for 15 minutes for the
development of the enzymatic reaction of horseradish
peroxidase. ELISA readings in terms of optical density
(OD) were measured immediately by microplate reader
A-1764A (Beckman) at wavelength of 492 nm [16].
Duplicate wells of negative control, distilled water instead
of serum, and duplicate wells of positive control solutions
(Wellcome) at standardized working concentration, 10
ug/mL of EBV VCA antigen, were used at each run of
ELISA. Since ELISA was used for measuring the burden of
EBV serum IgG and IgA antibodies for comparative pur-
poses among the studied risk factor groups of HNCA
patients, no cutoff value was needed for demarcating sera
into seronegative or seropositive nor calibration curve was
needed to measure the real concentration of antigens.
Statistical analysis
The statistical analysis was preformed using software Sta-
tistica version 6.1.478.0 and MS Excel 2000. ELISA OD
values were presented as mean ± 2 standard error. After
confirming the normal distribution pattern of ELISA val-
ues by Kolmogorov and Smirnov tests, parametric multi-
variate student t-tests were used to evaluate the
significance of difference among the mean ELISA OD
readings for EBV serum IgG and IgA antibodies. For qual-
itative categorized data (number of subjects showing cer-
tain event), the significance of association was measured
by applying Chi square test of independence for contin-
gency tables and corrected by Fishers' Exact test when
needed. The histograms used for ELISA OD mean values
were shown with error bars and p values of significant dif-
ference, while histograms of observational data, number
of subjects and their parentages, were not shown with p
values and error bars as chi square test for independence
measures the significant association of variables' fre-
quency rather than the significant difference of the varia-
bles' values.
Results
Serum level of EBV IgG and IgA antibodies
ELISA was used to assess the serum level of EBV IgG and
IgA antibodies among HNCA patients in comparison with
that of control subjects. The serum IgG and IgA level in
HNCA patients, 0.165 ± 0.02 and 0.175 ± 0.09 respec-
tively, were not significantly higher than in control sub-
jects, 0.13 ± 0.018 and 0.094 ± 0.007 respectively (p >
0.05). Similarly, EBV serum level of IgG and IgA antibod-
ies in both CL, 0.132 ± 0.009 and 0.1 ± 0.04 respectively,
and HPC, 0.126 ± 0.01 and 0.11 ± 0.03 respectively,
patients was not significantly higher than in control group
(p > 0.05). On the other hand NPC was the only group
that showed a significantly higher serum level of EBV IgG
and IgA antibodies, 0.352 ± 0.045 and 0.453 ± 0.08
respectively, than control group (p < 0.01). Furthermore,
NPC group showed far highest IgG and IgA levels in com-
parison with CL and HPC (p < 0.001) (Table 1, Fig. 1 andBMC Public Health 2008, 8:400 http://www.biomedcentral.com/1471-2458/8/400
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Table 1: The mean ± 2 standard error of ELISA OD readings of EBV serum IgG and IgA antibodies in control, HNCA, NPC, CL, and 
HPC groups
Group Mean ELISA OD EBV serum IgG Mean ELISA OD EBV serum IgA
Control 0.13 ± 0.018 0.094 ± 0.007
HNCA 0.165 ± 0.02 0.175 ± 0.09
NPC 0.352 ± 0.045 0.453 ± 0.08
CL 0.132 ± 0.009 0.1 ± 0.04
HPC 0.126 ± 0.01 0.11 ± 0.03
This histogram shows the difference in the mean serum level of EBV IgG antibodies measured in ELISA OD in HNCA as one  group, NPC, HPC, and CL patients as well as control subjects Figure 1
This histogram shows the difference in the mean serum level of EBV IgG antibodies measured in ELISA OD in 
HNCA as one group, NPC, HPC, and CL patients as well as control subjects. The mean serum level of EBV IgG anti-
bodies in NPC patients was significantly higher than in CL, HPC, HNCA and control groups.
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Fig. 2). This indicated a strong association between EBV
and NPC represented by very high levels of serum EBV IgG
and IgA antibodies. Therefore, EBV seems to play an
essential role as biological risk factor for the development
of NPC rather than other types of HNCA. On the other
hand, there was no association between EBV serum IgG
and IgA level and staging of the disease (p > 0.05).
The histological characteristics of HNCA patients
SCC was dominant in HNCA patients except for NPC
patients who elicited a different histological profile in that
large proportion of highly undifferentiated carcinoma,
namely LE, was found. It was 12 (28.5%) of NPC patients
whose histopathological paraffin-embedded sections
showed SCC versus 30 (71.4%) LE. In CL group, 57
(86.3%) patients whose histopathological paraffin-
embedded sections were SCC, 6 (9%) undifferentiated LE
and 3 (4.5%) adenocarcinoma. In HPC group, the his-
topathological paraffin-embedded sections of all patients
were SCC (Table 2 and Fig. 3). The chi square test of inde-
pendence showed that NPC group was associated with LE
versus CL and HPC groups were associated with SCC (p <
0.05). In addition, the serum level of EBV IgG and IgA
antibodies proved to be associated with tumor histology.
Mean ELISA readings of EBV serum IgG and IgA antibod-
ies in NPC patients with LE, 0.397 ± 0.036 and 0.527 ±
0.076 respectively, were much higher than that of NPC
patients with SCC, 0.239 ± 0.067 (p < 0.05) and 0.268 ±
0.09 respectively (p < 0.01) (Table 3 and Fig. 4). This pro-
vided evidence that EBV is associated clearly with the
undifferentiated NPC of LE histology rather than differen-
tiated NPC of SCC histology. And this association can be
This histogram shows the difference in the mean serum level of EBV IgA antibodies measured in ELISA OD in HNCA as one  group, NPC, HPC, and CL patients as well as control subjects Figure 2
This histogram shows the difference in the mean serum level of EBV IgA antibodies measured in ELISA OD in 
HNCA as one group, NPC, HPC, and CL patients as well as control subjects. The mean serum level of EBV IgA anti-
bodies in NPC patients was significantly higher than in CL, HPC, HNCA and control groups.
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estimated well by monitoring EBV serum antibodies espe-
cially IgA antibodies which reflected this association more
obviously than IgG antibodies. Although 9% of CL
patients were of LE tumors, no similar association was
found between EBV serum IgG and IgA level and CL
tumor histology. The serum level of IgG, 0.135 ± 0.01, and
IgA, 0.11 ± 0.032, in CL patients with LE tumors was not
different from that in CL patients with SCC tumors, 0.131
± 0.008 and 0.093 ± 0.044 respectively (p > 0.05) (Table
3). This provided another clue on the particular associa-
tion of EBV with LE histology of NPC rather than other
types of HNCA.
Age and Sex factors in HNCA patients
There was no insignificant difference among the mean age
of NPC, HPC and CL patients, 54 ± 3.6, 62.16 ± 4.1, and
50.81 ± 5.3 respectively providing evidence that age of
HNCA patients was not distinct for each type of HNCA (p
> 0.05). In attempt to disclose any possible association of
NPC patients age with EBV serum IgG and IgA antibodies,
the median age of NPC patients, 54.4 years, was used to
group NPC patients into above-median age group and
below-median age group. The serum level of EBV IgA,
0.486 ± 0.073, in below-median age group was higher
than that, 0.3 ± 0.082, in above-median age group (p <
0.05) but the serum level of IgG, 0.314 ± 0.039, in below-
median age group was not higher than that, 0.327 ±
0.047, in above-median age group (p > 0.05) (Table 3 and
Fig. 5). Age of NPC, CL, and HPC patients was not associ-
ated with the staging of the disease (p > 0.05).
It was shown that sex ratio in HNCA groups was signifi-
cantly different from each other (p < 0.01) in that HPC
group showed the lowest male:female ratio, 1:6, then
NPC, 3.6:1 and the highest ratio was found in CL, 10:1.
On the other hand, sex of NPC patients did not show a
significant association with EBV serum antibodies (p >
0.05) like that shown in the age of NPC patients. There
was no association between sex ratio and age of patients
and staging of the disease (p > 0.05).
Table 2: The number and percentage of patients/subjects with the studied observations of this study in control, NPC, CL, and HPC 
groups
Variable NPC N(%) CL N(%) HPC N(%) Control N(%)
Histopathology of tumors:
SCC 12 (28.5) 57 (86.3) 14 (100) -
LE 30 (71.4) 6 (9%) 0 -
adenocarcinoma 0 3 (4.5) 0 -
Regular smokers 36 (85.7) 47 (71.2) 4 (28.6) 25 (36.7)
Regular alcohol consumers 18 (42.8) 10 (15.1) 3 (21.4) 9 (13.3)
SCC in the regular alcohol consumers 9 (50) - - -
SCC in the non-regular alcohol consumers 3 (12.5) - - -
HNCA-positive family history 6 (14.3) 33 (50%) 9 (64.3) -
Table 3: The mean ± 2 standard error of ELISA OD readings of EBV serum IgG and IgA antibodies in different subgroups of NPC and 
CL patients
Group Mean ELISA OD EBV serum IgG Mean ELISA OD EBV serum IgA
NPC patients with LE 0.397 ± 0.036 0.527 ± 0.076
NPC patients with SCC 0.239 ± 0.067 0.268 ± 0.09
CL patients with LE 0.135 ± 0.01 0.11 ± 0.032
CL patients with SCC 0.131 ± 0.008 0.093 ± 0.044
Below-median age group of NPC 0.314 ± 0.039 0.486 ± 0.073
Above-median age group of NPC 0.327 ± 0.047 0.3 ± 0.082
Regular smokers in NPC 0.379 ± 0.043 0.493 ± 0.084
Non- regular smokers in NPC 0.19 ± 0.057 0.213 ± 0.056
Regular alcohol consumers in NPC 0.325 ± 0.05 0.466 ± 0.072
Non-regular alcohol consumers in NPC 0.372 ± 0.041 0.445 ± 0.086
HNCA-positive family history group of NPC 0.2 ± 0.065 0.177 ± 0.1
HNCA-negative family history group of NPC 0.377 ± 0.041 0.499 ± 0.076BMC Public Health 2008, 8:400 http://www.biomedcentral.com/1471-2458/8/400
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Smoking
It was found that 81 (66.3%) of HNCA patients were reg-
ular smokers while only 25 (36.7%) of controls were reg-
ular smokers (p < 0.01). It was also found that 36 (85.7%)
of NPC patients, 4 (28.6%) of HPC patients and 47
(71.2%) of CL patients were regular smokers (Table 2 and
Fig. 6). NPC and CL groups were both remarkably associ-
ated with high percentage of regular smokers in compari-
son with HPC patients and control subjects (p < 0.01).
Interestingly, there was a significant association between
the serum level of EBV IgG and IgA antibodies and smok-
ing. The mean ELISA reading of EBV IgG and IgA antibod-
ies in the regular smokers group of NPC patients, 0.379 ±
0.043 and 0.493 ± 0.084 respectively, was much higher
than that of the non-regular smokers group, 0.19 ± 0.057
and 0.213 ± 0.056 respectively (p < 0.01) (Table 3 and Fig.
7). This indicated that smoking was associated with EBV
and the regular smokers group of NPC patients showed
higher serum EBV IgG and IgA antibodies than non-smok-
ers which highlighted a probable link between smoking
and NPC via certain role of EBV. However, smoking habit
in NPC group was not associated with histology, age, stag-
ing of the disease, or sex (p > 0.05).
Alcohol consumption
Twenty eight (23%) of HNCA patients and 9 (13.3%) of
control group were regular alcohol consumers (p > 0.05).
The percentage of regular alcohol consumers in NPC was
18 (42.8%), in HPC 3 (21.4%) and in CL 10 (15.1%)
(Table 2 and Fig. 8). Accordingly, the percentage of the
regular alcohol consumers in NPC patients was very high
if compared with CL, HPC and control group which indi-
cated that NPC was significantly associated with regular
alcohol intake (p < 0.01) while other types of HNCA were
This histogram shows the percentage of patients with tissue sections of SCC and LE tumors in each group of HNCA patients Figure 3
This histogram shows the percentage of patients with tissue sections of SCC and LE tumors in each group of 
HNCA patients. It was shown that LE tumors were associated with NPC group while SCC tumors were associated with CL 
and HPC groups.
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not. Therefore, regular alcohol consumption might be one
of the remarkable risk factor for developing NPC disease.
Unlike smoking, alcohol risk factor might be more inter-
esting in the epidemiology of NPC as other HNCA groups
did not show any similar association with alcohol intake.
On the other hand, there was no significant association
between the serum level of EBV IgG and IgA antibodies
and the regular alcohol intake in NPC group. The mean
ELISA readings of EBV serum IgG and IgA in the regular
alcohol consumers of NPC group, 0.325 ± 0.05 and 0.466
± 0.072 respectively, were not different from that in the
non-regular alcohol consumers group, 0.372 ± 0.041 and
0.445 ± 0.086 respectively (p > 0.05), (Table 3 and Fig. 9).
It was also shown that the percentage of NPC patients
with SCC in the regular alcohol consumers, 9 (50%), was
higher than that in the non-regular alcohol consumers, 3
(12.5%) which indicated a significant association of SCC
tumors of NPC with alcohol intake (p < 0.05) (Table 2).
Since SCC histology was associated with much lower lev-
els of EBV serum IgG and IgA, the link between SCC and
alcohol intake might give a clue on different mechanisms/
risk factors for NPC development where EBV does not
play an important role as risk factor like in LE histology.
However, alcohol intake in NPC group was not associated
with smoking, age, staging of the disease, or sex (p > 0.05).
Positive family history of the disease
There were 48 HNCA patients (39.3%) who showed pos-
itive family history of HNCA, i.e. a history of HNCA
within the first 3 degree relatives, namely parents, broth-
ers/sisters and cousins. It was shown that 6 (14.3%) of
NPC patients revealed positive family history. On the
other hand, HPC and CL patients revealed 9 (64.3%) and
33 (50%) patients respectively with positive family his-
tory (Table 2 and Fig. 10). The lowest percentage of
patients with HNCA-positive family history was in NPC
group which was associated significantly with the negative
HNCA family history group (p < 0.05) while CL and HPC
were associated significantly with positive family history
group (p < 0.05), This points out to the notion that posi-
tive family history of the disease is not one of the effective
risk factors for NPC development. This implies to the pres-
This histogram shows the significant higher mean values of EBV serum IgG and IgA antibodies, measured in ELISA OD, in NPC  patients with LE tumors than in NPC patients with SCC tumors Figure 4
This histogram shows the significant higher mean values of EBV serum IgG and IgA antibodies, measured in 
ELISA OD, in NPC patients with LE tumors than in NPC patients with SCC tumors.
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ence of more effective risk factors of NPC than the familial
inheritance of the disease.
One of the interesting results, the HNCA-positive family
history group of NPC patients revealed far lower level of
EBV IgG and IgA antibodies, 0.2 ± 0.065 and 0.177 ± 0.1
respectively, than in the HNCA-negative family history
group, 0.377 ± 0.041 (p < 0.05) and 0.499 ± 0.076 respec-
tively (p < 0.01), (Table 3 and Fig. 11) rendering the
HNCA-negative family history group of NPC the most
affected by EBV infection and vice versa. There was no
association found between the HNCA-family history and
histology, sex, age, staging of the disease, smoking, and
alcohol intake (p > 0.05).
Discussion
This study explored the complicated network of risk fac-
tors of NPC and other types of HNCA in one of the highly
NPC-endemic regions in the world, the Middle East. The
role of EBV as a risk factor of NPC was the pivotal line of
research that all other risk factors were linked to. The strat-
egy of this research was comparing the studied risk factors
in; HNCA patients as one group versus control subjects
and different HNCA groups versus control subjects and
with each other. Moreover, it was aimed at comparing
EBV serum level of IgG and IgA antibodies in different
subgroups of NPC patients.
NPC patients showed the highest level of serum EBV IgG
and IgA antibodies when compared to the studied HNCA
groups and control group. This is in agreement with many
published reports that explored the association between
EBV and HNCA in general and NPC in particular [17-20].
Elevated antibody titers to EBV antigens, e.g. early anti-
gens, viral capsid antigens are frequently found in NPC
patients and have been considered as important markers
in the diagnosis and prognosis of these EBV-associated
diseases [17,18]. It's a special feature of NPC that patients
This histogram shows the significant higher mean values of EBV serum IgA but not IgG antibodies, measured in ELISA OD, in  NPC patients with age below the median cutoff value (54.4 years) than in NPC patients with age above the median cutoff value  (54.4 years) Figure 5
This histogram shows the significant higher mean values of EBV serum IgA but not IgG antibodies, measured 
in ELISA OD, in NPC patients with age below the median cutoff value (54.4 years) than in NPC patients with 
age above the median cutoff value (54.4 years).
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sustain high levels of a broad spectrum of EBV antibodies
especially those for IgA and IgG subtypes directly against
both latent and lytic viral antigens [19,20]. Accordingly,
this study showed that EBV association with NPC in the
Middle East is congruous with other NPC endemic regions
and provide evidence that EBV is one of the most influen-
tial risk factors for the development of NPC in this region.
There was no age distinction for each type of HNCA. The
mean age of the studied HNCA groups was higher than 50
years. This revealed that age of more than 50 years could
be considered as a risk factor for HNCA development.
Interestingly, higher level of EBV serum IgA but not IgG
was found in NPC patients who were younger than the
median age cutoff line, 54.4 years. This finding showed
that older NPC patients were affected less by EBV as a risk
factor of NPC development. This might give a clue that the
high burden of EBV infection could accelerate the occur-
rence of NPC in the population and this is supported by a
previous report [4] stating that the mean age of NPC
patients in South East Asia is lower than in Western coun-
tries. This might be explained by the context of our results
that EBV is a leading risk factor in high endemic regions of
NPC like South East Asia and the Middle East which might
accelerate NPC incidence making the mean age of NPC
patients in high endemic regions less than that in western
countries where EBV is less frequently associated with
NPC. However, it is not clear why EBV serum IgG antibod-
This histogram shows the percentage of the regular smokers in the studied groups of HNCA as well as in the control subjects Figure 6
This histogram shows the percentage of the regular smokers in the studied groups of HNCA as well as in the 
control subjects. NPC and CL groups were associated with the regular smoking habit when compared to the control and 
HPC groups.
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ies were not associated with younger NPC patients like IgA
antibodies. One of the possible explanations, the older
NPC patients might undergo severe immune suppression
which affects the IgA antibodies more than the long-last-
ing IgG antibodies. However, this might need further
investigation in a separate study to focus on this point of
the research. Nevertheless, because EBV serum IgA anti-
bodies are more specific than IgG antibodies in respect to
NPC development, the association of EBV serum IgA anti-
bodies with younger NPC patients was an interesting find-
ing.
Male: female ratio in HNCA patients was 2.6:1 which
reflected a male predominance over females. Many
reports have confirmed this outcome and revealed that
under 45 years of age the incidence in men was double
that in women, with the increasing age the rate of inci-
dence increase accelerated more in men than in women
[21,22]. HNCA groups showed different sex ratios. The
male predominance in CL and NPC belongs largely to the
nature of the risk factors in the Middle East society which
affects males more than females. Men are more apt to be
exposed to different risk factors due to the outdoor nature
of work that most females in this region are not actively
involved in. Therefore, most females, especially in the
rural areas do house keeping jobs where less chances of
exposure to pollution, occupational factors, passive smok-
ing in the public regions, stress-induced immune suppres-
sion that help trigger EBV reactivation. Nevertheless, most
HPC patients were females. It is worth mentioning that
there was no previous report revealed female predomi-
nance in HPC patients like what found in this study. This
needs further investigation to elucidate the reasons of this
peculiar sex ratio in HPC patients in this region of the
world.
The histopathology of NPC patients in this study was
extensively different from that of other HNCA patients.
The highly undifferentiated carcinoma, namely LE was
dominant in NPC patients rather than SCC which was
dominant in other HNCA groups. This attracts attention
to the unique profile of risk/triggering factors of NPC
which lead to different profiles of histopathology. In addi-
tion, the serum level of EBV IgG and IgA antibodies was
significantly higher in LE group than SCC group of NPC
patients confirming the principal role of EBV in the etiol-
This histogram shows the significant higher mean values of EBV serum IgG and IgA antibodies, measured in ELISA OD, in the  regular smokers group of NPC patients than in the non-regular smokers group of NPC patients Figure 7
This histogram shows the significant higher mean values of EBV serum IgG and IgA antibodies, measured in 
ELISA OD, in the regular smokers group of NPC patients than in the non-regular smokers group of NPC 
patients.
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ogy of NPC especially the undifferentiated LE type of
NPC. There is a study [22] stated that EBV is associated vir-
tually with all cases of undifferentiated NPC, lymphoepi-
thelioma, and has been classified as group I carcinogen.
Therefore, the exclusive high percentage of LE tumors in
NPC patients together with the unusual high levels of EBV
serum IgG and IgA in NPC versus other HNCA groups and
in LE group versus SCC group of NPC patients have led to
the suggestion that EBV in the Middle East, or might be in
any other high endemic region, plays a central role in the
NPC development favoring LE histology on other types of
HNCA histology.
In this study, smoking proved to be an important risk fac-
tor for the development of HNCA. The number of regular
smokers among HNCA patients was much higher than in
control group. Such results have been recorded in other
parts of the world. A prospective study in the USA showed
that heavy smokers die due to carcinoma of larynx 32
folds than age-adjusted non-smokers, and of oral cavity
cancer, more than 24 folds [23]. Nevertheless, this report
stated a bit different results of our study which revealed
that the rank of the highest numbers of regular smoker
was in NPC, CL, and then HPC patients. Therefore, smok-
ing seems much more effective in the etiology of NPC in
the Middle East patients than in the patients of other parts
This histogram shows the percentage of the regular alcohol consumers in the studied groups of HNCA as well as in the con- trol subjects Figure 8
This histogram shows the percentage of the regular alcohol consumers in the studied groups of HNCA as well 
as in the control subjects. NPC was the only group associated with alcohol intake when compared to CL, HPC, and control 
groups.
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of the world. In addition, the EBV serum level of both IgG
and IgA antibodies was significantly higher in the regular
smokers group of NPC than in the non-regular smoker
group. This referred to a possible link between smoking
and EBV in respect to NPC etiology or propagation. These
findings together indicate that NPC is largely affected by
smoking habit which is associated significantly with
higher EBV serum antibodies and this point out to the
possibility that cigarette smoke components are one of the
initiative factors for EBV reactivation within nasopharyn-
geal mucosa. This needs further investigation to dig deep.
Once the relationship between EBV-induced NPC and
smoking could be confirmed, this will open new measures
for NPC epidemiology and prevention.
Unlike smoking habit, the percentage of regular alcohol
consumers in HNCA patients was not significantly higher
than in control group, except for NPC patients who
showed a remarkable higher percentage of regular alcohol
consumers than control subjects and other HNCA
patients. This provided evidence that alcohol intake could
acts as one of the important risk factors of NPC develop-
ment. And this affection was not seen in other HNCA
types making alcohol intake of particular significance to
NPC patients. This finding is supported by a previous
report showed that excessive alcohol consumption
increases the risk of incurring cancers of oral cavity, phar-
ynx and to a lower extent larynx [24]. Anyhow, our study
did not reveal a significant association of alcohol intake
with CL as shown by [24]. Unlike smoking, this study
revealed no association between alcohol intake and EBV
in NPC patients which might indicate that alcohol intake
is an EBV-independent risk factor for the development of
NPC. Hence, another factor might be associated with alco-
hol intake in respect to NPC development rather than
EBV. It was found that the dominant histology in the reg-
ular alcohol consumers group of NPC was SCC while in
the non-regular alcohol consumers group was LE. This
finding gave a clue that alcohol could affect NPC develop-
ment away from EBV effect which was significantly related
to LE histology. Accordingly, it was proposed that alcohol
intake might be the most influential risk factor of SCC
This histogram shows that there was no significant difference in the mean values of EBV serum IgG and IgA antibodies, meas- ured in ELISA OD, between the regular alcohol consumers group and the non-regular alcohol consumers group of NPC  patients Figure 9
This histogram shows that there was no significant difference in the mean values of EBV serum IgG and IgA 
antibodies, measured in ELISA OD, between the regular alcohol consumers group and the non-regular alcohol 
consumers group of NPC patients.
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tumors but not LE tumors of NPC. In other words, alcohol
intake might be the most important risk factor of NPC
development out of the indirect effect of EBV infection.
Cancer is a disease of multifactorial etiology involving
environmental and genetic factors. The genetic suscepti-
bility is best measured by the family history of the disease
[24,25]. In this study, NPC patients showed the lowest
percentage of positive family history of the disease among
HNCA. Statistical analysis clarified that NPC group was
associated significantly with the negative family history of
the disease while other HNCA groups were associated sig-
nificantly with the positive family history of the disease.
This implies to the notion that the environmental risk fac-
tors most probably play more important role in the etiol-
ogy of NPC than the familial genetic factors. Moreover,
the positive family history group of NPC showed far lower
levels of serum EBV IgG and IgA antibodies than negative
family history group. These findings together referred to
many points to discuss. First, NPC is most affected by
environmental than genetic factors. Second, patients with
genetically predisposed NPC are unlikely associated with
EBV as a risk or predisposing factor. Third, EBV etiology of
NPC patients is less likely affected by familial and inherit-
able susceptibility and it acts as an independent risk fac-
tor. Therefore, it was proposed that the familial
This histogram shows the percentage of HNCA patients with positive family history of the disease Figure 10
This histogram shows the percentage of HNCA patients with positive family history of the disease. CL and HPC 
groups, but not NPC group, were associated with positive family history of the disease. Therefore, the majority of NPC 
patients, unlike CL and HPC patients, were of negative family history of the disease.
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carcinogenic background of NPC patients might not be so
essential for it's etiology like in CL and HPC suggesting
that the biological and environmental risk factors are
dominant over the genetic factors for NPC development.
NPC is often difficult to be diagnosed because of the non-
specific nature of its clinical symptoms and the difficulty
in visualizing the nasopharynx [26]. Most of NPC tumors
remain undiagnosed until metastasis to the cervical
lymph nodes occurs, often without overt pathology at the
primary site [27,28] which indicates the desperate need
for an early diagnosis and early treatment strategies to
improve survival. Early detection of NPC should improve
cure rate and reduce morbidity and metastasis. Taking
into account the high incidence of NPC in many regions
of the world and its difficult early diagnosis, hence the
determination of the correct high risk groups of NPC in
every society seems invaluable and life saving. EBV sero-
logical screening assays might be one of the reliable
means for the population screening of NPC.
Conclusion
Taken together, NPC showed a particular profile of risk
factors that deviate much from other HNCA groups. NPC
was particularly affected and triggered/promoted by EBV,
LE tumors, alcohol intake, smoking habit, male patients.
Unlike other studied HNCA groups, NPC was not affected
much by HNCA-positive family history. On the other
hand, the risk factors influence the development of other
HNCA patients were smoking, increased age, male
patients for CL and female patients for HPC, positive fam-
ily history, and SCC tumors. Interestingly, this study also
showed that higher levels of serum EBV IgG and IgA anti-
bodies in NPC patients were associated with HNCA-nega-
tive family history, regular smoker group of NPC, LE
histology of NPC, and younger NPC patients. In contrast,
EBV serum antibodies were not associated with regular
alcohol consumers or the sex of NPC patients. Hence,
smoking and LE histology in NPC group might act as
dependent risk factors via reactivating EBV infection. In
contrast, alcohol consumption was associated with SCC
This histogram shows the significant higher mean values of EBV serum IgG and IgA antibodies, measured in ELISA OD, in NPC  patients with negative family history of the disease than in NPC patients with positive family history of the disease Figure 11
This histogram shows the significant higher mean values of EBV serum IgG and IgA antibodies, measured in 
ELISA OD, in NPC patients with negative family history of the disease than in NPC patients with positive fam-
ily history of the disease.
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tumor of NPC rather than higher levels of serum EBV IgG
antibodies indicating that alcohol consumption is an
EBV-independent risk factor for the development of NPC
mainly of SCC histology. In addition, EBV risk factor
might hasten the incidence of NPC patients in younger
age. This study clarified the central role of EBV in control-
ling other risk factors of NPC making this disease distinct
in terms of risk factors profile and incidence distribution.
In addition, it is thought that a screening test for measur-
ing the serum level of EBV IgA and IgG antibodies in the
correctly determined high risk groups of a population will
help much establish the correct basis for the early diagno-
sis and proper treatment of NPC patients.
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